CRISPR技术市场规模、份额和成长分析（按产品/服务、应用、最终用户和地区划分）—产业预测（2026-2033年）

全球 CRISPR 技术市场预计到 2024 年价值为 35 亿美元，到 2025 年将成长至 40.8 亿美元，到 2033 年将成长至 138.4 亿美元，预测期（2026-2033 年）复合年增长率为 16.5%。

受基因组编辑技术进步的推动，全球CRISPR技术市场正经历显着成长。这项革命性的工具能够对DNA序列进行精确修改，使研究人员能够解决基因缺陷、对抗疾病并提高农业生产力。 CRISPR利用合成的引导RNA和Cas9核酸酶，实现标靶基因组修饰，包括基因元件的移除或插入。 CRISPR在微生物学领域的应用不断扩展，加上基因研究投入的不断增加，进一步增强了其市场潜力。然而，儘管市场成长迅速，但伦理考量和专业知识匮乏等挑战可能会阻碍其进一步扩张。 CRISPR的应用范围涵盖疾病治疗到农业改良，凸显了其在现代生物技术和基因工程中的重要角色。

全球 CRISPR 技术市场驱动因素

全球CRISPR技术市场的成长受到多种因素的推动，这些因素共同促进了基因编辑领域的发展。北美和欧洲等已开发地区对基因研究的资金投入不断增加，大大推动了市场扩张。这些地区政府主导的倡议，促使对基因发现所需的创新材料、先进设备和新技术进行大量投资。此外，这些资金也推动了罕见遗传疾病医疗解决方案的研发。同时，欧洲国家人类基因组研究所等机构的支持，在推动基因组研究方面发挥关键作用，进一步巩固了市场潜力。

限制全球CRISPR技术市场的因素

全球CRISPR技术市场面临许多限制因素，主要源自于CRISPR治疗方法的高成本。开发和生产先进的基因编辑治疗方法需要大量的时间、资源和投资，导致成本增加。由于CRISPR基因检测试剂盒和治疗方案的价格限制了其普及，最终这些经济负担会转嫁到病人身上。因此，高成本阻碍了这项创新技术的广泛应用，也为CRISPR市场的整体成长和覆盖范围带来了挑战，使其难以服务于需要基因介入的各类人群。

全球CRISPR技术市场趋势

将人工智慧 (AI) 和机器学习 (ML) 应用于基因编辑流程是全球 CRISPR 技术市场的一大趋势。这种融合透过改进靶点识别和最大限度地减少脱靶效应，提高了 CRISPR 应用的准确性和效率。凭藉先进的数据分析能力，AI 和 ML 正在加速药物研发和诊断等各领域的治疗标靶发现过程。随着这些技术的不断发展，它们有望进一步革新基因编辑，推动研发创新，拓展潜在应用范围，从而显着促进 CRISPR 市场的成长。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析

全球 CRISPR 技术市场规模（按产品/服务划分）及复合年增长率（2026-2033 年）

• 产品
  • CRISPR试剂盒和酶
  • CRISPR文库
  • 其他产品
  • 设计工具
  • 抗体
  • 其他试剂
• 服务
  • gRNA设计与载体构建
  • 细胞株工程
  • 筛检服务
  • 表观基因编辑
  • 转录活化
  • 其他的

全球 CRISPR 技术市场规模：按应用和复合年增长率 (2026-2033)

• 药物发现与开发
• 农业
• 其他的
  • 生质燃料
  • 兽医学

全球 CRISPR 技术市场规模（按最终用户划分）及复合年增长率（2026-2033 年）

• 製药和生物技术公司
• 学术和研究机构
• 其他的
  • CRO
  • CDMO

全球 CRISPR 技术市场规模（按地区划分）及复合年增长率（2026-2033 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• CRISPR Therapeutics（Switzerland/USA）
• Intellia Therapeutics（USA）
• Editas Medicine（USA）
• Beam Therapeutics（USA）
• Mammoth Biosciences（USA）
• Caribou Biosciences（USA）
• Synthego（USA）
• ERS Genomics（Ireland）
• Takara Bio（Japan）
• Merck KGaA（Germany）
• Thermo Fisher Scientific（USA）
• Danaher Corporation（Integrated DNA Technologies（IDT））（USA）
• Horizon Discovery（PerkinElmer Inc.）（UK/USA）
• GenScript（USA）
• Agilent Technologies（USA）
• New England Biolabs（USA）
• Cellectis（France）
• Sangamo Therapeutics（USA）
• Addgene（USA）
• Biocytogen Co., Ltd.（China）

结论与建议

Global CRISPR Technology Market size was valued at USD 3.50 Billion in 2024 and is poised to grow from USD 4.08 Billion in 2025 to USD 13.84 Billion by 2033, growing at a CAGR of 16.5% during the forecast period (2026-2033).

The global CRISPR technology market is experiencing significant growth driven by advancements in genome editing capabilities. This revolutionary tool enables precise modifications of DNA sequences, allowing researchers to address genetic defects, combat diseases, and enhance agricultural yields. By leveraging synthetic guide RNA and Cas9 nuclease, CRISPR facilitates targeted genomic alterations, including the removal or insertion of genetic components. The rising application of CRISPR in microbiology, coupled with increasing investments in genetic research, reinforces its market potential. Despite this growth, ethical considerations and a scarcity of specialized knowledge present challenges that could hinder further expansion. Applications range from disease treatment to agricultural improvements, highlighting CRISPR's crucial role in modern biotechnology and genetic engineering.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global CRISPR Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global CRISPR Technology Market Segments Analysis

Global CRISPR Technology Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Products and Services. Based on Application, the market is segmented into Drug discovery & development, Agriculture and Other applications. Based on End User, the market is segmented into Pharmaceutical & biotechnology companies, Academic & research institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global CRISPR Technology Market

The growth of the global CRISPR technology market is driven by a multitude of factors that enhance the gene editing sector. An uptick in financial support for genetic research in developed regions like North America and Europe is significantly bolstering market expansion. Government initiatives in these areas are channeling substantial investments into innovative materials, advanced equipment, and novel techniques for genetic exploration. Additionally, such funding fosters the advancement of medical solutions targeting rare genetic disorders. Furthermore, support from entities like the National Human Genome Research Institute in Europe plays a crucial role in propelling genomics research forward, further solidifying the market's potential.

Restraints in the Global CRISPR Technology Market

The Global CRISPR Technology market faces significant constraints primarily due to the high costs associated with CRISPR-based therapies. Developing and manufacturing advanced genome editing treatments require extensive time, resources, and investment, leading to increased expenses. This financial burden ultimately falls on patients, as the accessibility of CRISPR gene detection kits and therapeutic options is limited by their price. Consequently, the high costs hinder widespread adoption and utilization of these innovative technologies, posing a challenge to the overall growth and reach of the CRISPR market as it seeks to serve a diverse population in need of genetic interventions.

Market Trends of the Global CRISPR Technology Market

The Global CRISPR Technology market is witnessing a significant trend towards the integration of artificial intelligence (AI) and machine learning (ML) into gene editing processes. This fusion enhances the precision and efficiency of CRISPR applications by improving target identification and minimizing off-target effects. Leveraging advanced data analysis capabilities, AI and ML are accelerating the therapeutic target discovery process within various sectors, including drug development and diagnostics. As these technologies evolve, they are expected to further revolutionize gene editing, fostering innovation in research and expanding the range of potential applications, thereby driving substantial growth in the CRISPR market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global CRISPR Technology Market Size by Product & Services & CAGR (2026-2033)

• Market Overview
• Products
  • CRISPR kits & Enzymes
  • CRISPR Libraries
  • Other Products
  • Design Tools
  • Antibodies
  • Other Reagents
• Services
  • GRNA Design & Vector Construction
  • Cell Line Engineering
  • Screening Services
  • Other Services
  • Epigenome Editing
  • Transcriptional Activation

Global CRISPR Technology Market Size by Application & CAGR (2026-2033)

• Market Overview
• Drug discovery & development
• Agriculture
• Other applications
  • Biofuels
  • Veterinary

Global CRISPR Technology Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical & biotechnology companies
• Academic & research institutes
• Others
  • CROs
  • CDMOs

Global CRISPR Technology Market Size & CAGR (2026-2033)

• North America (Product & Services, Application, End User)
  • US
  • Canada
• Europe (Product & Services, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Services, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Services, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Services, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• CRISPR Therapeutics (Switzerland/USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intellia Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Editas Medicine (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beam Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mammoth Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caribou Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synthego (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ERS Genomics (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (Integrated DNA Technologies (IDT)) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horizon Discovery (PerkinElmer Inc.) (UK/USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellectis (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sangamo Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Addgene (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocytogen Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations